GENERAL29 Sept 2026
Small-cap pharma stock rallies 178% in 2026, extends winning run into fifth year; key factors behind rally | Stock Market News
Cupid, a consumer wellness company, saw its shares rise 178% in 2026, after a 584% jump in 2025. It also joined the FTSE Emerging Markets All Cap Index in September 2026. Strong orders and profit growth are driving this rally. Retail investors hold a 52.8% stake, so they benefit most. If you hold the stock, review your position and avoid chasing past returns.
Key Statutory Highlights
- Cupid's shares gained 178% in 2026, after a 584% rise in 2025.
- The company's June quarter total income grew 142% year-on-year to ₹157 crore, while profit after tax rose 194% to ₹44 crore.
- Retail investors together held a 52.8% stake in the company at the end of the June quarter.
Actionable Advice for Taxpayers / Founders:If you already hold Cupid, check what share of your portfolio this one small-cap stock now makes up, since a run this steep can swing both ways. Do not buy only because of past returns, and consider speaking to a registered adviser before adding more.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: